Hospira is recalling hundreds of infusion pumps widely used to deliver nutrients and medicines to patients in hospitals, nursing homes and in the home for home care due to a defect that could cause an interruption in therapy and thus lead to serious and/or life threatening situations.
The affected infusion pumps involve the Hospira Plum A+ and Plum A+3, which were manufactured and distributed nationwide from July 2012 to May 2014.
The Plum A+ and A+3 infusion pumps have an alarm that should sound when therapy is interrupted. However, some of the alarms may fail to sound in situations that should trigger it. It is possible for a long delay before a health care professional becomes aware of the need to restore therapy.
No injuries, illnesses or deaths associated with the defect have been reported. However, for patients receiving critical intravenous medication, there is a risk of injury resulting from this prolonged interruption in therapy. Serious patient injury or death is possible.
Last year, Hospira issued recalls on its Acclaim Encore Infusion Pumps because of a defect that could lead to over-infusion of medications, and its GemStar Infusion Pump due to a power supply error that could cause a delay in therapy. The company has also issued dozens of recalls on various injectable medications due to contamination with mold, metal bits, glass fragments and even human hair.
Any adverse events or quality issues involving Hospira infusion pumps should be reported to the Food and Drug Administration (FDA) MedWatch Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.